Fusibact-B Cream is a dermatological medication primarily used to treat bacterial skin infections, such as eczema and dermatitis. Bacterial infection occurs when harmful bacteria grow in the body and causes disease. It can infect any part of the body and multiply very quickly. Eczema is a condition in which skin patches become inflamed, itchy, cracked, and rough. Some types of eczema can also lead to blisters (a small bubble on the skin filled with serum and is caused by friction, burning, or other damage). Dermatitis is a skin condition that causes itchy, dry skin or a rash on swollen, reddened skin. 

Fusibact-B Cream is composed of two medicines: Beclomethasone dipropionate (corticosteroid) and Fusidic acid (antibiotic). Beclomethasone dipropionate belongs to the class of corticosteroids. Corticosteroids have anti-inflammatory, immunosuppressive, and antiproliferative (inhibit cell growth) properties. Beclomethasone dipropionate blocks prostaglandins (chemical messengers) production that make the affected area red, swollen, and itchy. It effectively treats inflammation and itchiness caused by eczema (inflamed and itchy skin) and psoriasis (skin cells build up and form scales and itchy, dry patches). On the other hand, Fusidic acid is an antibiotic and prevents the synthesis of essential proteins required by bacteria to carry out vital functions. It is used to treat infections like dermatitis (inflammation of the skin), spots, cuts, grazes, impetigo (weeping, crusty and swollen patch of skin), and folliculitis (inflammation of one or more hair follicles).

Your doctor will advise the appropriate dose that suits your infection. Fusibact-B Cream has common side effects like itching, dryness, redness, and burning sensation at the application site. These side effects usually do not require medical attention and gradually resolve over time. However, if you face any other symptoms or the side effects persist longer, please consult your doctor.

Let your doctor know if you have any allergic reactions to Fusibact-B Cream or other medications. Do not use Fusibact-B Cream on thin skin, broken veins, skin ulcers, or acne without the doctor's advice. Do not apply tight dressings and bandages on the skin's affected areas after using Fusibact-B Cream unless the doctor advised. Fusibact-B Cream is not recommended for use in diaper rash. Do not use Fusibact-B Cream on sensitive areas like nostrils, ears, lips, or genitals if the doctor did not advise you. Pregnant and breastfeeding mothers should consult the doctor before starting Fusibact-B Cream. 

Fusibact-B Cream is used to treat bacterial skin infections, such as eczema and dermatitis. It consists of two medicines: Beclomethasone dipropionate (corticosteroid) and Fusidic acid (antibiotic). Beclomethasone dipropionate blocks prostaglandins production (chemical messengers) that make the affected area red, swollen, and itchy. It is used to treat inflammation and itchiness caused by eczema (inflamed and itchy skin) and psoriasis (skin cells build up and form scales and itchy, dry patches). On the other hand, Fusidic acid is an antibiotic and prevents the synthesis of essential proteins required by bacteria to carry out vital functions. It is used to treat infections like dermatitis (inflammation of the skin), spots, cuts, grazes, impetigo (weeping, crusty and swollen patch of skin), and folliculitis (inflammation of one or more hair follicles).

Avoid contact of Fusibact-B Cream with nose, mouth or eyes as it may irritate. In case Fusibact-B Cream comes in contact with these areas accidentally, rinse with water thoroughly. If you are pregnant, breastfeeding mother or are planning to conceive, please consult a doctor before using Fusibact-B Cream. Avoid smoking or going near naked flames since Fusibact-B Cream can catch fire and burn easily. Tell your doctor before using Fusibact-B Cream if you have heart, kidney or liver problems before using Fusibact-B Cream. Fusibact-B Cream is not recommended to use for diaper rash.

It is advised to reach out to your doctor if the bacterial infection symptoms persist or worsen after two weeks of treatment.